NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against XP Inc. (NASDAQ: XP), The Vita Coco Company, Inc. (NASDAQ: COCO), KinderCare Learning Companies, Inc. (NYSE: KLC), and SelectQuote, Inc. (NYSE: SLQT). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided. XP Inc. (NASDAQ: XP) On March 12, 2025, Grizzly Research published a report entitled "XP's (Nasdaq: XP) Entire Profits Are Dependent on What Insiders Call a ‘Madoff-Like Ponzi Scheme'". The Grizzly Research report alleges, among other things, that XP "is running a massive Ponzi scheme facilitated through certain derivatives sales to retail clients, which are funneled through special funds and misrepresented as proprietary trading profits." Following publication of the report, XP's stock price fell $0.82 per share, or 5.48%, to close at $14.14 per share on March 12, 2025. For more information on the XP investigation go to: https://bespc.com/cases/XP The Vita Coco Company, Inc. (NASDAQ: COCO) On March 26, 2025, Ningi Research published a report alleging that “Vita Coco is suffering from structural internal deficiencies, such as undisclosed related-party transactions and supply chain mismanagement.” Following this report, the price of the Company’s stock dropped. For more information on the Vita Coco investigation go to: https://bespc.com/cases/COCO KinderCare Learning Companies, Inc. (NYSE: KLC) On or around October 9, 2024, KinderCare conducted its initial public offering ("IPO"), selling 24 million shares of common stock priced at $24.00 per share. Then, on March 20, 2025, KinderCare issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 28, 2024 and provided guidance for 2025. Among other items, KinderCare reported an operational loss of $89.3 million in the fourth quarter of 2024, contrasting with an operational income of $48.7 million in the previous year. KinderCare attributed the loss primarily to increased equity-based compensation expenses and lower COVID-19 stimulus reimbursements. KinderCare also provided full-year guidance that fell short of consensus estimates. On this news, KinderCare's stock price fell $3.92 per share, or 22.17%, to close at $13.76 per share on March 21, 2025. For more information on the KinderCare investigation go to: https://bespc.com/cases/KLC SelectQuote, Inc. (NYSE: SLQT) On May 1, 2025, the U.S. Department of Justice (“DOJ”) announced the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including SelectQuote, “alleg[ing] that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.” On news of the DOJ’s lawsuit, SelectQuote’s stock price fell $0.61 per share, or 19.24%, to close at $2.56 per share on May 1, 2025. For more information on the SelectQuote investigation go to: https://bespc.com/cases/SLQT About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Marion Passmore, Esq. (212) 355-4648 [email protected] www.bespc.com
Bragar Eagel & Squire, P.C. Is Investigating XP, Vita Coco, KinderCare, and SelectQuote and Encourages Investors to Contact the Firm
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...